European Companies Search Engine

Merger: Seracell Stammzelltechnologie GmbH 15 Aug 2019 – German Trade Register Announcement, Germany

Overview

Text

HRB 14625: Seracell Pharma GmbH, Rostock,
Schillingallee 68, 18057 Rostock
. The company is merged as the acquiring entity with the Seracell Stammzelltechnologie GmbH with its registered office in Rostock (District Court of Rostock HRB 9342) in accordance with the merger agreement of August 12, 2019 as well as the approval decisions of its shareholders' meeting of August 12, 2019 and the shareholders' meeting of the transferring entity of August 12, 2019. The creditors of the companies participating in the merger must be deemed to have declared their claim in writing in writing within six months of the date on which the registration of the merger in the register of the registered office of the entity of which they are creditors is deemed to have been made known in accordance with Paragraph 19 (3) of the UmwG, provided that they cannot claim satisfaction. However, creditors are only entitled to this right if they demonstrate that the merger jeopardises the fulfilment of their claim.

This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The current state is available on the following page: Seracell Pharma GmbH, Rostock, Germany.

Creative Commons License The visualizations for "Seracell Pharma GmbH - Merger: Seracell Stammzelltechnologie GmbH" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.